ReviewFrontiers in immunology2025

Molecular mechanisms and clinical applications of gut microbiota-derived bioactive compounds in metabolic dysfunction-associated fatty liver disease.

Chengyun Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.